当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 资产负债表

宏源药业

(301246)

  

流通市值:24.29亿  总市值:60.36亿
流通股本:1.61亿   总股本:4.00亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金437,835,714.18745,590,069.831,021,446,462.93763,824,133
应收票据及应收账款547,529,463.73526,540,762.91496,964,335.2495,337,798.53
其中:应收票据267,563,892.63290,116,454.87234,699,831.41211,648,145.31
应收账款279,965,571.1236,424,308.04262,264,503.79283,689,653.22
应收款项融资76,543,147.1132,903,555.0353,151,904.6136,963,084.69
预付款项35,265,361.2438,504,497.3638,122,99221,833,598.13
其他应收款合计81,169,855.0579,886,496.2381,055,950.9480,221,424.9
存货288,108,965.26270,528,377.11238,623,488.82234,191,630.23
其他流动资产452,269,573.02452,087,706.59421,543,360.99328,811,739.49
流动资产平衡项目0000
流动资产合计3,101,788,369.333,046,358,976.713,016,003,560.553,047,583,272.49
非流动资产:
长期股权投资198,631,845.9203,642,857.22205,708,779.46213,545,927.03
投资性房地产3,915,824.053,936,801.683,957,779.313,978,756.94
固定资产1,607,678,874.371,653,912,916.931,425,720,465.841,464,810,426.32
在建工程668,912,164.01630,574,445.25876,608,341.92791,302,319.06
使用权资产7,462,842.487,705,618.876,783,744.356,963,618.39
无形资产182,280,997.92181,892,927.66179,885,940.89181,046,940.25
长期待摊费用4,806,583.055,519,338.523,326,779.863,876,674.85
递延所得税资产18,883,922.1717,256,375.9815,902,624.7816,417,299.23
其他非流动资产79,383,750.0674,123,300.39122,760,946.71114,790,552.9
非流动资产平衡项目0000
非流动资产合计2,771,956,804.012,778,564,582.52,840,655,403.122,796,732,514.97
资产平衡项目0000
资产总计5,873,745,173.345,824,923,559.215,856,658,963.675,844,315,787.46
流动负债:
短期借款168,060,167.5859,317,883.3555,401,696.727,337,181.33
应付票据及应付账款756,146,484.3777,271,649.26841,896,769.5871,340,602.49
其中:应付票据375,706,836.69344,279,217.59352,476,784.89401,369,757.58
应付账款380,439,647.61432,992,431.67489,419,984.61469,970,844.91
合同负债18,217,745.2213,874,566.3221,867,225.5214,819,597.04
应付职工薪酬12,435,026.7628,149,495.7712,413,262.214,305,227.25
应交税费11,177,890.396,816,710.654,054,649.22,597,997.23
其他应付款合计41,166,957.7133,927,264.7746,211,687.871,800,429.92
应付股利---19,900,340
一年内到期的非流动负债77,974,607.4877,746,048.7768,928,604.9868,889,314.74
其他流动负债99,041,206.32138,885,290.97127,695,272.82110,689,914.31
流动负债平衡项目0000
流动负债合计1,184,220,085.761,135,988,909.861,178,469,168.741,161,780,264.31
非流动负债:
长期借款227,584,000230,361,000238,061,000240,838,000
租赁负债6,817,449.467,164,120.197,184,737.037,132,183.52
递延收益75,414,253.1668,641,367.3364,619,904.5166,891,783.69
递延所得税负债22,143,449.0721,621,624.6221,462,569.9321,346,375.3
非流动负债平衡项目0000
非流动负债合计331,959,151.69327,788,112.14331,328,211.47336,208,342.51
负债平衡项目0000
负债合计1,516,179,237.451,463,777,0221,509,797,380.211,497,988,606.82
所有者权益(或股东权益):
实收资本(或股本)400,006,800400,006,800400,006,800400,006,800
资本公积2,172,614,891.52,172,316,086.472,172,141,087.072,172,082,219.76
减:库存股47,149,748.232,795,729.2731,405,166.1431,157,176.11
专项储备4,958,580.423,370,156.843,659,149.783,268,258.86
盈余公积190,536,938.83190,536,938.83185,239,736.88185,239,736.88
未分配利润1,636,131,654.961,627,245,582.721,617,219,975.871,616,887,341.25
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,357,099,117.514,360,679,835.594,346,861,583.464,346,327,180.64
少数股东权益466,818.38466,701.62--
股东权益平衡项目0000
股东权益合计4,357,565,935.894,361,146,537.214,346,861,583.464,346,327,180.64
负债和股东权益合计5,873,745,173.345,824,923,559.215,856,658,963.675,844,315,787.46
公告日期2025-04-252025-04-252024-10-252024-08-30
审计意见(境内)标准无保留意见
TOP↑